Is aurora kinase-C-T191D constitutively active mutant?
These findings proved that Aurora C-T191D is not hyperactive but is constitutively active mutant.
Galantide and M35 ameliorated the severity of AP, but M40 and C7 had mixed effects. Complex galanin pathways may be involved in cerulein-induced AP. M35 and galantide are potential therapeutic peptides for the treatment of AP and further evaluation should be considered. and IAP.